In addition, human AR-negative prostate cancer patient-derived xenografts were found to exhibit strong osteoinductive activity, all while overexpressing FGF9 and WNT ligands, highlighting the role of both pathways in mediating AR-independent prostate cancer progression and metastatic spreading to the bone [196]. The gene discussed is FGF9; the disease is prostate cancer.